Stay up to date with the latest news
Subscribe to our telegram channel
Enterprise on production of medicaments for endocrine diseases to be created in Tashkent
Tashkent, Uzbekistan (UzDaily.com) --
Eli Lilly (the United States) and Tarchomin Polfa (Poland) will implement a project on organization of production of medicaments for treatment of endocrine diseases in 2014-2015.
The project will be implemented in Tashkent. The project cost is US$12 million, of which US$8 million will be direct investments of the foreign companies.
The project was included into the investment programme of Uzbekistan for 2014. It is planned to use investments for US$3 million in 2014.
After the launch, the enterprise will produce 5 million conditions units of products a year.
LATEST NEWS